Turn to the worm!

Current Opinion in Genetics and Development

Volumn 7, Issue 3, 1997, Pages 410-415

  Ahringer, Julie ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA;

ANIMAL GENETICS; CAENORHABDITIS ELEGANS; DRUG SCREENING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SEQUENCE; GENOME; HUMAN GENETICS; MUTANT; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SHORT SURVEY;

ANIMALIA; CAENORHABDITIS ELEGANS; METAZOA;

EID: 0030750494     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(97)80157-8     Document Type: Article

References (42)

1. Riddle DL, Blumenthal T, Meyer BJ, Priess JR: C. elegans II. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1997. A new Bible of C. elegans development and behavior that complements rather than replaces the original one [3]; a must for anyone working with C. elegans or interested in how it relates to their research.
2. Epstein HF, Shakes DC: Methods in cell biology. In Caenorhabditis elegans: Modern Biological Analysis of an Organism, vol 48. San Diego: Academic Press; 1995. An extremely useful book, covering most common methods used in C. elegans research. It also gives background on the basic biology behind techniques, examples where they have been successful and help with troubleshooting and experiment design.
3. Wood WB: The Nematode Caenorhabditis elegans. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1988.
4. White JG, Southgate E, Thomson JN, Brenner S: The structure of the nervous system of Caenorhabditis elegans. Philos Trans R Soc Lond 1987, 314:1-340.
5. Berks M: The C. elegans genome sequencing project. Genome Res 1995, 5:99-104.
6. Chan SSY, Zheng H, Su MW, Wilk R, Killeen MT, Hedgecock EM, Culotti JG: UNC-40, a C. elegans homolog of DCC (Deleted in Colorectal Cancer), is required in motile cells responding to UNC-6 netrin cues. Cell 1996, 87:187-195.
7. Wadsworth WG, Hedgecock EM: Hierarchical guidance cues in the developing nervous-system of C. elegans. Bioessays 1996, 18:355-362.
8. Griff IC, Reed RR: The genetics of olfaction. Curr Opin Genet Dev 1995, 5:657-661.
9. Coburn CM, Bargmann CI: A putative cyclic nucleotide-gated channel is required for sensory development and function in C. elegans. Neuron 1996, 17:695-706.
10. Sengupta P, Chou JH, Bargmann CI: odr-10 encodes a 7 transmembrane domain olfactory receptor required for responses to the odorant diacetyl. Cell 1996, 84:899-909.
11. Komatsu H, Mori I, Rhee JS, Akaike N, Ohshima Y: Mutations in a cyclic nucleotide-gated channel lead to abnormal thermosensation and chemosensation in C. elegans. Neuron 1996, 17:707-718.
12. Burdine RD, Stern MJ: A C. elegans FGF-like molecule is involved in sex myoblast migration. Mol Biol Cell 1995, 6:1216.
13. Devore DL, Horvitz HR, Stern MJ: An FGF receptor signaling pathway is required for the normal cell migrations of the sex myoblasts in C. elegans hermaphrodites. Cell 1995, 83:611-620.
14. Kornfeld K: Vulval development in Caenorhabditis elegans. Trends Genet 1997, 13:55-61.
15. Bassett DE, Boguski MS, Hieter P: Yeast genes and human disease. Nature 1996, 379:589-590.
16. Bassett DE, Basrai MA, Connelly C, Hyland KM, Kitagawa K, Mayer ML, Morrow DM, Page AM, Resto VA, Skibbens RV et al.: Exploiting the complete yeast genome sequence. Curr Opin Genet Dev 1996, 6:763-766.
17. Guo S, Kemphues KJ: par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative ser/thr kinase that is asymmetrically distributed. Cell 1995, 81:611-620.
18. Mello C, Fire A: DNA transformation. Methods Cell Biol 1995, 48:451-482.
19. Zwaal RR, Broeks A, Van Meurs J, Groenen JTM, Plasterk RH: Target-selected gene inactivation in Caenorhabditis elegans by using a frozen transposon insertion mutant bank. Proc Natl Acad Sci USA 1993, 90:7431-7435.
20. Plasterk RHA: Reverse genetics - from gene sequence to mutant worm. Methods Cell Biol 1995, 48:59-80.
21. Rushforth AM, Saari B, Anderson P: Site-selected insertion of the transposon Tc1 into a Caenorhabditis elegans myosin light chain gene. Mol Cell Biol 1993, 13:902-910.
22. Broeks A, Janssen H, Calafat J, Plasterk RHA: A P-glycoprotein protects Caenorhabditis elegans against natural toxins. EMBO J 1995, 14:1858-1866.
23. Broeks A, Gerrard B, Allikmets R, Dean M, Plasterk RHA: Homologs of the human multidrug-resistance genes MRP and MDR contribute to heavy-metal resistance in the soil nematode Caenorhabditis elegans. EMBO J 1996, 15:6132-6143. A very nice use of reverse genetic knockout worms. Here and in [22], the authors made targeted deletions in C. elegans homologs of MRP and MDR type multidrug resistance genes and initiated a functional study. They found that both MRP and MDR proteins give protection from toxic compounds (here being heavy metals) and that animals missing one gene of each type are hypersensitive, suggesting that they somehow act together.
24. Collins FS: Cystic-fibrosis - molecular biology and therapeutic implications. Science 1992, 256:774-779.
25. Hanson I, Van Heyningen V: Pax6 - more than meets the eye. Trends Gene? 1995, 11:268-272.
26. Chisholm AD, Horvitz HR: Patterning of the Caenorhabditis elegans head region by the Pax-6 family member vab-3. Nature 1995, 377:52-55.
27. Quiring R, Waldorf U, Kloter U, Ghering W: Homology of the eyeless gene of Drosophila to the small eye gene in mice and Aniridia in humans. Science 1994, 265:785-789.
28. Grainger RM: New perspectives on embryonic lens induction. Semin Cell Dev Biol 1996, 7:149-155.
29. Derynck R, Zhang Y: Intracellular signaling - the Mad way to do it Curr Biol 1996, 6:1226-1229.
30. Savage C, Das P, Finelli AL, Townsend SR, Sun CY, Baird SE, Padgett RW: Caenorhabditis elegans genes sma2, sma-3, and sma-4 define a conserved family of transforming growth-factor-beta pathway components. Proc Natl Acad Sci USA 1996, 93:790-794.
31. Artavanis-Tsakonas S, Matsuno K, Fortini ME: Notch signaling. Science 1995, 268:225-232.
32. Levitan D, Greenwald I: Facilitation of lin-12-mediated signaling by sel-12, a Caenorhabditis elegans S182 Alzheimers-disease gene. Nature 1995, 377:351-354.
33. Alzheimer's Disease Collaborative Group: The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet 1995, 11:219-222.
34. Levitan D, Doyle TG, Brousseau D, Lee MK, Thinakaran G, Slunt HH, Sisodia SS, Greenwald I: Assessment of normal and mutant human presenilin function In Caenorhabditis elegans. Proc Natl Acad Sci USA 1996, 93:14940-14944. The use of C. elegans as a system for studying the function of human presenilins, genes that can be mutated to cause Alzheimer's disease. In previous work [32], the authors showed that the gene sel-12 encodes a presenilin homolog. Here, they found that intact presenilins can substitute for SEL-12 in vivo whereas the Alzheimer's disease causing mutant genes tested all have reduced activity. This provides an assay system and a starting point for further functional studies of human presenilins.
35. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:1456-1462.
36. Metzstein MM, Hengartner MO, Tsung N, Ellis RE, Horvitz HR: Transcriptional regulator of programmed cell-death encoded by Caenorhabditis elegans gene ces-2. Nature 1996, 382:545-547. The authors of this paper show that ces-2, a cell-death-specification gene, encodes a basic region leucine-zipper transcription factor. Intriguingly, ces-2 is homologous to HLF, an oncogenic form of which inhibits programmed cell death in mammalian cells. The authors suggest that the normal role of HLF may be like that of ces-2, to negatively regulate a cell survival gene and that the oncogenic form has positive rather than negative activity.
37. Inaba T, lnukai T, Yoshihara T, Seyschab H, Ashmun RA, Canman CE, Laken SJ, Kastan MB, Look AT: Reversal of apoptosis by the leukemia-associated E2a-HLF chimeric transcription factor. Nature 1996, 382:541-544.
38. Shaham S, Horvitz HR: An alternatively spliced C. elegans ced-4 RNA encodes a novel cell-death inhibitor. Cell 1996, 86:201-208. Further molecular study of ced-4, a genetically identified cell-death gene. The authors describe a new alternatively spliced form of ced-4. The previously identified ced-4 transcript (ced-4S) can induce programmed cell death whereas the newly identified one (ced-4L) protects cells from programmed cell death. They propose that the balance between the opposing ced-4 functions determines whether a cell either lives or dies. A mammalian ced-4-like gene has not yet been found but is predicted to exist.
39. Rand JB, Johnson CD: Genetic pharmacology - interactions between drugs and gene products in Caenorhabditis elegans. Methods Cell Biol 1995, 48:187-204.
40. Miller KG, Alfonso A, Nguyen M, Crowell JA, Johnson CD, Rand JB: A genetic selection for Caenorhabditis elegans synaptic transmission mutants. Proc Natl Acad Sci USA 1996, 93:12593-12598. A beautiful demonstration of the power of selecting mutants with altered response to a drug. The authors isolated a large number of mutants resistant to inhibitors of cholinesterase. Many of the genes identified were found to be generally involved in synaptic transmission, whereas others act specifically in the acetylcholine pathway.
41. Rushforth AM, Anderson P: Splicing removes the Caenorhabditis elegans transposon Tc1 from most mutant pre-messenger-RNAs. Mol Cell Biol 1996, 16:422-429.
42. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 1990, 215:403-410.